abstract |
This invention concerns combinations of inhibitors of MEK, Raf protein kinases, and other kinases includin VEGFRl -3 and PDGFR-β.. This invention also concerns pharmaceutical compositions comprising the compounds described herein and methods of use of the compounds and compositions described herein, including the use in the treatment and/or prevention of cancer and other hyperproliferative disorders. |